Cargando…
Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice
Efficacy of immune checkpoint inhibitors in cancers can be limited by CD8 T cell dysfunction or HLA-I down-regulation. Tumor control mechanisms independent of CD8/HLA-I axis would overcome these limitations. Here, we report potent CD4 T cell-mediated tumor regression and memory responses in humanize...
Autores principales: | Lin, Wen, Singh, Varan, Springer, Raynel, Choonoo, Gabrielle, Gupta, Namita, Patel, Aditi, Frleta, Davor, Zhong, Jun, Owczarek, Tomasz, Decker, Corinne, Macdonald, Lynn, Murphy, Andrew, Thurston, Gavin, Mohrs, Markus, Ioffe, Ella, Lu, Yi-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130128/ https://www.ncbi.nlm.nih.gov/pubmed/37185301 http://dx.doi.org/10.1038/s42003-023-04812-3 |
Ejemplares similares
-
Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice
por: Gao, Jie, et al.
Publicado: (2023) -
Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse model
por: Patel, A. K., et al.
Publicado: (2023) -
A framework for highly multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity
por: Zhang, Wen, et al.
Publicado: (2021) -
IL-6–GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models
por: Carbonaro, Marisa, et al.
Publicado: (2023) -
Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy
por: Decker, Corinne E., et al.
Publicado: (2019)